Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing
to market innovative central nervous system therapies. Allons lead drug davunetide is proceeding in a pivotal clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special... More
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.